$50.0 Million
Menlo Therapeutics Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$111.0 Million
Evofem Biosciences, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$100.0 Million
BioCryst Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$45.0 Million
Ocular Therapeutix, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$60.0 Million
Gamida Cell Ltd.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$132.0 Million
Akebia Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$120.0 Million
Aeglea BioTherapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
$85.3 Million
Sutro Biopharma, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$115.1 Million
Crinetics Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$97.8 Million
SeaSpine Holdings Corporation
Confidentially Marketed Follow-On Offering
Active Bookrunner
Subscribe to Active Bookrunner

© 2024 Piper Sandler Companies. Since 1895. All rights reserved.